ELI-002
Elicio Therapeutics
['rectal', 'colorectal', 'eli-002 ', 'pancreatic', '$ibb', 'elicio', 'elicio,(-delicious)', '$xbi']
$eltx elicio therapeutics' eli-002 shows positive interim results in phase 1 study for patients with high relapse risk pancreatic and colorectal cancer, as presented at asco annual meeting. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt